KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Beginning Cash Balance: 2017-2025

Historic Beginning Cash Balance for Elanco Animal Health (ELAN) over the last 9 years, with Sep 2025 value amounting to $539.0 million.

  • Elanco Animal Health's Beginning Cash Balance rose 29.57% to $539.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $490.0 million, marking a year-over-year increase of 32.79%. This contributed to the annual value of $352.0 million for FY2024, which is 2.03% up from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Beginning Cash Balance is $539.0 million, which was up 10.68% from $487.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Beginning Cash Balance high stood at $638.0 million for Q1 2022, and its period low was $318.0 million during Q2 2023.
  • Over the past 3 years, Elanco Animal Health's median Beginning Cash Balance value was $369.0 million (recorded in 2023), while the average stood at $408.7 million.
  • The largest annual percentage gain for Elanco Animal Health's Beginning Cash Balance in the last 5 years was 51.50% (2021), contrasted with its biggest fall of 58.30% (2021).
  • Elanco Animal Health's Beginning Cash Balance (MRQ) stood at $453.0 million in 2021, then rose by 1.55% to $460.0 million in 2022, then decreased by 19.78% to $369.0 million in 2023, then soared by 32.79% to $490.0 million in 2024, then rose by 10.00% to $539.0 million in 2025.
  • Its last three reported values are $539.0 million in Q3 2025, $487.0 million for Q2 2025, and $468.0 million during Q1 2025.